Testing a virus called M032 in children and adults with newly diagnosed diffuse midline glioma
Official title: Engineered HSV-1 M032 for the Treatment of Children and Adults With Newly Diagnosed Diffuse Midline Glioma After Standard of Care Radiation
Status: Recruiting. It is looking for patients now. Talk to your care team about whether it fits you.
The trial team last updated this record on .
The short version
This trial is testing whether a lab made virus, put right into the tumor, is safe for people with this brain tumor after they finish radiation.
Read our full plain-language summary
What the trial team says
The goal of this clinical research study is to learn about the safety and effects of M032 given directly into the tumor in children and adults with DMG and who have received standard-of-care radiation therapy.
Key facts
- Registry number
- NCT07076498
- Stage of testing
- Phase 1
- Conditions studied
- Glioma
Where it is running
This trial lists 1 site.
-
Texas
- The University of Texas M. D. Anderson Cancer Center (Houston)
How to use this
Talk to your care team first. They know your history and can tell you whether this trial is worth your time.
Joining a trial is always your choice. A trial is a test, not a proven treatment. Being in one is not a promise that it will help you.
This page is built from the trial's listing on ClinicalTrials.gov, a service of the U.S. National Library of Medicine. That listing is the authority, and it may have changed since we last read it. We do not run this trial and we cannot enroll you in it.